Corcept Therapeutics Inc
SWB:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
Enbridge Inc
F:EN30
|
CA |
|
C
|
Coca-Cola Co
SWB:CCC3
|
US |
|
Lithium Americas Corp
F:WUC
|
CA |
|
C
|
Caixabank SA
XMUN:48CA
|
ES |
|
Thungela Resources Ltd
F:6UP
|
ZA |
|
A
|
Altria Group Inc
LSE:0R31
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 77.99 EUR with a low forecast of 43.88 EUR and a high forecast of 123.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
77.99
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 77.99 EUR with a low forecast of 43.88 EUR and a high forecast of 123.17 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
32%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 3 years is 32%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
148%
The compound annual growth rate for Operating Income over the next 3 years is 148%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
108%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 108%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
68%
The compound annual growth rate for Net Income over the next 3 years is 68%.
